Adage Capital Partners Gp, L.L.C. Centessa Pharmaceuticals PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,119,027 shares of CNTA stock, worth $90.2 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
5,119,027
Previous 4,195,000
22.03%
Holding current value
$90.2 Million
Previous $67.1 Million
27.83%
% of portfolio
0.16%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding CNTA
# of Institutions
107Shares Held
119MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$352 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$176 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$171 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$111 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$105 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.66B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...